HR Stock Forecast & Price Target

Healthcare Realty Trust is well positioned because it is the only pure-play public medical office building REIT, with 562 properties and 32.8 million square feet concentrated on- or adjacent-campus, supporting durable demand tied to hospital systems. Its recent execution on HR 2.0, including stronger health system relationships with CommonSpirit, Wellstar, and Ascension, suggests better portfolio quality, while the $392 million development and redevelopment pipeline should add about $0.05 per share of earnings accretion once stabilized. Fundamental support also comes from healthy leverage at 5.6x net debt to EBITDA, roughly $75 million of annual cash retention, and expected FFO growth to $1.64 in 2026, $1.69 in 2027, and $1.76 in 2028.

Healthcare Realty Trust is facing a negative outlook because its core leasing trends are weakening, with Q1 Lantower performance decelerating, blended lease spreads slipping to 3.5% erosion, and occupancy down 120bp quarter over quarter, while management still expects only modest improvement later. The portfolio also appears over-pressured by execution risk: $300 million of lease-up spending is needed to drive just $50 million of incremental NOI, asset sales of $1.2 billion may come at higher cap rates and dilute earnings, and some lease extensions and dispositions may not occur until 2028. Despite improved liquidity to $966 million and lower debt/GBV at 42.6%, IFRS NAVPU fell to $15.96 and the 19% takeover discount to NAV underscores weak underlying asset valuation and limited upside.